Short description
LOWTIYEL® 1% is indicated for replacement treatment in men with conditions associated with deficiency or absence of endogenous testosterone:
to. Primary hypogonadism (congenital or acquired).
b. Hypogonadotropic hypogonadism (congenital or acquired): LOWTIYEL® 1% has not been clinically evaluated in males under 18 years of age.
Leave your review